Research across Respiratory Failure
Related studies from across the Respiratory Failure family.
11 trials tracked for nasal obstruction: 2 in phase 3 or 4 and 1 with published results. The most-cited published study has 7 citations.
Showing the 11 most-cited and recently-updated of 11 trials. Browse the full registry →
Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.
Interventions for nasal obstruction include the use of the Vivaer Stylus, which demonstrated significant improvements in Nasal Obstruction Symptom Evaluation (NOSE) scores. Specifically, studies reported mean reductions in NOSE scores ranging from -44.5 7 to -53.3 9, with high responder rates noted in multiple trials [9, 11]. Long-term follow-up for the Vivaer Stylus showed sustained improvements in NOSE scores of 25.7 and 32.3 9.
Nasal implants have been shown to significantly reduce nasal airway obstruction as measured by a Visual Analog Scale (VAS) with mean reductions between -34.3 and -41.7 (p<0.001) 8. Additionally, nasal implants demonstrated high responder rates in clinical evaluations, reaching up to 147% in certain cohorts [8, 10].
In contrast, pharmacological management with Triamcinolone Acetonide did not result in a statistically significant difference in NOSE scores compared to a placebo saline spray (p=0.7) 2. However, patients who underwent surgery following the initial treatment period showed significant improvements in NOSE scores compared to pre-surgical levels (p<0.001) 2.
AI synthesis of 8 cited trials, updated Jun 25, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.
Related studies from across the Respiratory Failure family.